StockNews.com assumed coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on ...

At close: April 14 at 4:00:02 PM EDT ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Health experts unravel modern detox myths and stress the importance of good diet, an active lifestyle and a long-term ...

The U.S.-China trade war has gone full Metal Jacket — we’re well past the tariff tit-for-tat and barreling into total ...

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Xtant Medical Holdings (XTNT – Research Report).

DelveInsight "Carcinoid Tumor Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain disruptions and that favorable tax policies would be a more effective tool ...

It later moved into medicines, commercialising aspirin around the turn of the 20th century, one of the most successful pharmaceuticals ever at that point. The unregulated nature of the trade in ...